These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38958586)

  • 1. Androgen receptor post-translational modifications and their implications for pathology.
    Montoya-Novoa I; Gardeazábal-Torbado JL; Alegre-Martí A; Fuentes-Prior P; Estébanez-Perpiñá E
    Biochem Soc Trans; 2024 Aug; 52(4):1673-1694. PubMed ID: 38958586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy.
    Kumar R; Atamna H; Zakharov MN; Bhasin S; Khan SH; Jasuja R
    Life Sci; 2011 Mar; 88(13-14):565-71. PubMed ID: 21284948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion.
    MacLean HE; Warne GL; Zajac JD
    J Neurol Sci; 1996 Feb; 135(2):149-57. PubMed ID: 8867071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor-related diseases: what do we know?
    Shukla GC; Plaga AR; Shankar E; Gupta S
    Andrology; 2016 May; 4(3):366-81. PubMed ID: 26991422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
    Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
    Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New routes to therapy for spinal and bulbar muscular atrophy.
    Rocchi A; Pennuto M
    J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
    Baniahmad A
    J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal and Bulbar Muscular Atrophy Overview.
    Fischbeck KH
    J Mol Neurosci; 2016 Mar; 58(3):317-20. PubMed ID: 26547319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations and AR gene mutations in Kennedy's disease.
    Liu X; Zhu M; Li X; Tang J
    Funct Integr Genomics; 2019 May; 19(3):533-539. PubMed ID: 30612224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
    Pennuto M; Rinaldi C
    Mol Cell Endocrinol; 2018 Apr; 465():113-121. PubMed ID: 28688959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy).
    MacLean HE; Choi WT; Rekaris G; Warne GL; Zajac JD
    J Clin Endocrinol Metab; 1995 Feb; 80(2):508-16. PubMed ID: 7852512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
    Cortes CJ; La Spada AR
    Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
    Lumahan LEV; Arif M; Whitener AE; Yi P
    Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment.
    Grunseich C; Fischbeck KH
    Curr Opin Neurol; 2020 Oct; 33(5):629-634. PubMed ID: 32773451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications of nuclear receptors and human disease.
    Anbalagan M; Huderson B; Murphy L; Rowan BG
    Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
    Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
    Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review.
    Valera Yepes R; Virgili Casas M; Povedano Panades M; Guerrero Gual M; Villabona Artero C
    Endocrinol Nutr; 2015 May; 62(5):224-30. PubMed ID: 25857692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of androgen insensitivity.
    Brinkmann AO
    Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.
    Rusmini P; Bolzoni E; Crippa V; Onesto E; Sau D; Galbiati M; Piccolella M; Poletti A
    Neurobiol Dis; 2010 Nov; 40(2):361-9. PubMed ID: 20621188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.